Literature DB >> 21927874

[How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases].

M Schenck1, W Michels-Oswald, S Tschirdewahn, H Rübben, F Vom Dorp, A Rose, A Panic, C Niedworok, R Rossi.   

Abstract

BACKGROUND: Since 1999 urologists at the University of Essen in Germany have performed subcutaneous implantation of venous port systems, controlled by intravasal ECG.
METHODS: Between December 1999 and June 2011 implantation of venous port systems was performed in 241 male (69.5%) and 106 (30.5%) female patients. The port systems were implanted subcutaneously above the pectoralis major muscle under local anesthesia. If it was not possible to isolate the cephalic vein or safe catheter implantation was not feasible, puncture of the subclavian vein was performed.
RESULTS: The median follow-up was 491.6 days (2-2568), and 163.254 catheter days (mean 239 days, range 2-2604) were documented. During the follow-up period 191 (55.1%) patients died. The mean surgical implantation and explantation time was 36.5 min (14-85 min) and 25.4 min (10-46 min), respectively; 79.7% were implanted and controlled by ECG. Altogether, 390 devices were used in 379 surgical procedures, 355 implantations (91.1%) and 35 explantations (8.9%). Implanted vessels were the cephalic vein in 303 patients (85.6%) and the subclavian vein in 51 (14.4%) patients. Of 35 explanted devices, the explantation was necessary due to complications in 28 (8.0%) cases: infection n=6 (1.7%, 0.036 per 1,000 catheter days), occlusion n=8 (2.3%, 0.049 per 1,000 catheter days), dislocation n=7 (2.0%, 0.042 per 1,000 catheter days), deep vein thrombosis of the upper extremity n=6 (1.7%, 0.037 per 1,000 catheter days), and clotting n=1(0.3%, 0.006 per 1,000 catheter days). Premature catheter removal (<30 days post-op) was required in six cases (1.9%, 0.036 per 1,000 catheter days) due to complications: three catheter dislocations/malfunctions (0.9%, 0.019 per 1,000 catheter days), one port-related infection, one pocket port infection, and one deep vein thrombosis of the upper extremity (0.3%, 0.006 per 1,000 catheter days). Other problems described in the literature like pneumothorax, vein perforation, or pinch-off syndrome did not occur.
CONCLUSIONS: Implantation of port systems with ECG control of the catheter tip position is related to a few cases of adverse events and good surgical outcomes. Furthermore, it has also shown great advantages in offering immediate support and early therapy initiation with a fast learning curve for the training urologists. The results of the presented analysis are comparable to those of surgical or radiological departments reported in the literature and provide good evidence that this procedure should be extended to urological centers with a high volume of chemotherapy patients.

Entities:  

Mesh:

Year:  2012        PMID: 21927874     DOI: 10.1007/s00120-011-2715-3

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  26 in total

Review 1.  Central venous access catheters: radiological management of complications.

Authors:  U K Teichgräber; B Gebauer; T Benter; H J Wagner
Journal:  Cardiovasc Intervent Radiol       Date:  2003 Jul-Aug       Impact factor: 2.740

2.  Outcome analysis in 3,160 implantations of radiologically guided placements of totally implantable central venous port systems.

Authors:  Ulf K M Teichgräber; Stephan Kausche; Sebastian N Nagel; Bernhard Gebauer
Journal:  Eur Radiol       Date:  2011-01-05       Impact factor: 5.315

3.  Peripheral venous access ports: outcomes analysis in 109 patients.

Authors:  L J Bodner; J L Nosher; K M Patel; R L Siegel; R Biswal; C E Gribbin; R Tokarz
Journal:  Cardiovasc Intervent Radiol       Date:  2000 May-Jun       Impact factor: 2.740

4.  Subcutaneous ports in the radiology suite: an effective and safe procedure for care in cancer patients.

Authors:  M A de Gregorio; J M Miguelena; J A Fernández; C de Gregorio; A Tres; E R Alfonso
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 5.  The complications of central venous access systems: a study of 218 patients.

Authors:  J R Torramadé; J A Cienfuegos; J L Hernández; F Pardo; C Benito; J González; E Balén; V de Villa
Journal:  Eur J Surg       Date:  1993 Jun-Jul

6.  Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of device.

Authors:  R Biffi; G Martinelli; S Pozzi; S Cinieri; E Cocorocchio; F Peccatori; P F Ferrucci; R Pistorio; B Andreoni
Journal:  Bone Marrow Transplant       Date:  1999-07       Impact factor: 5.483

7.  Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.

Authors:  R E Schwarz; J S Groeger; D G Coit
Journal:  Cancer       Date:  1997-04-15       Impact factor: 6.860

8.  [Subclavian thrombosis after port system implantation].

Authors:  E Roller; T Ruzicka; K-W Schulte
Journal:  Hautarzt       Date:  2007-01       Impact factor: 0.751

9.  An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction.

Authors:  A Ignatov; O Hoffman; B Smith; J Fahlke; B Peters; J Bischoff; S-D Costa
Journal:  Eur J Surg Oncol       Date:  2008-03-10       Impact factor: 4.424

10.  Experience with subcutaneous infusion ports in three hundred patients.

Authors:  T E Brothers; L K Von Moll; J E Niederhuber; J A Roberts; S Walker-Andrews; W D Ensminger
Journal:  Surg Gynecol Obstet       Date:  1988-04
View more
  1 in total

1.  [Urological surgery with analogosedation and local anesthesia. What makes sense?].

Authors:  S Tschirdewahn; H Rübben; M Schenck
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.